OptimizeRx Corporation (OPRX) Q3 2025 Earnings Call Transcript [Seeking Alpha]
OptimizeRx Corporation (OPRX)
NASDAQ:AMEX Investor Relations:
optimizerx.com/investors
Company Research
Source: Seeking Alpha
Stephen Silvestro - President & CEO Edward Stelmakh - Chief Financial & Strategic Officer Andrew D'Silva - Chief Business Officer Conference Call Participants Ryan Daniels - William Blair & Company L.L.C., Research Division Richard Baldry - ROTH Capital Partners, LLC, Research Division David Grossman - Stifel, Nicolaus & Company, Incorporated, Research Division Eric Martinuzzi - Lake Street Capital Markets, LLC, Research Division Anderson Schock - B. Riley Securities, Inc., Research Division Jeffrey Garro - Stephens Inc., Research Division Presentation Operator Good afternoon, everyone, and thank you for joining OptimizeRx's Third Quarter Fiscal Year 2025 Earnings Conference Call. With us today is Chief Executive Officer, Steve Silvestro. He is joined by Chief Financial and Strategic Officer, Ed Stelmakh; Chief Legal and Administrative Officer, Marion Odence-Ford; and Chief Business Officer, Andrew D'Silva. At the conclusion of today's call, I will provide s
Show less
Read more
Impact Snapshot
Event Time:
OPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPRX alerts
High impacting OptimizeRx Corporation news events
Weekly update
A roundup of the hottest topics
OPRX
News
- OptimizeRx (OPRX): Clinical Network Growth Drives 37% Reach Boost Amid Analyst Upgrades [Yahoo! Finance]Yahoo! Finance
- OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare MarketingGlobeNewswire
- OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth Story [Seeking Alpha]Seeking Alpha
- OptimizeRx (NASDAQ:OPRX) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.MarketBeat
- OptimizeRx Continues Expansion of the Company's Point-Of-Care Network [Yahoo! Finance]Yahoo! Finance
OPRX
Earnings
- 11/6/25 - Beat
OPRX
Analyst Actions
- 11/17/25 - Stephens & Co.
OPRX
Sec Filings
- 12/23/25 - Form 4/A
- 12/23/25 - Form 4
- 12/23/25 - Form 4
- OPRX's page on the SEC website